Literature DB >> 17631968

Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia.

Leonidia Leonidou1, Athanassia Mouzaki, Marina Michalaki, Anna Lisa DeLastic, Venezana Kyriazopoulou, Harry P Bassaris, Charalambos A Gogos.   

Abstract

OBJECTIVES: To investigate whether stress hyperglycemia affects the production of the main pro- and anti-inflammatory cytokines and the 28-day hospital mortality in patients with severe sepsis.
METHODS: The study included 62 patients with severe sepsis, divided in three groups according to their glycemic profile within 24h after admission: patients with stress hyperglycemia (group SH, n=16), diabetes mellitus type II (group DM, n=27), and normal glucose levels (group NG, n=19). The serum levels of the cytokines TNF-alpha, IL-6, IL-10 and TGFbeta-1 were measured within 24h after admission.
RESULTS: A higher percentage of septic patients with stress hyperglycemia died compared to diabetic patients (43.7 vs. 14.8%) and group NG (43.7 vs. 5.2%). Group SH had higher SOFA score and levels of IL-6 and IL-10 than group DM and group NG. It also had higher levels of TNF-alpha than group DM but not group NG. There was no difference in the levels of TGFbeta-1 among the three groups. Non-survivors had higher levels of IL-10, no difference was detected for IL-6, TNF-alpha, IL-10/TNF-alpha ratio and TGFbeta-1. Interleukin-10 values, mean fasting glucose values and age were found as prognostic factors associated with outcome.
CONCLUSIONS: Stress hyperglycemia is associated with increased cytokine production and an adverse clinical outcome in patients with severe sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631968     DOI: 10.1016/j.jinf.2007.05.177

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  41 in total

1.  Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-01

Review 2.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

Review 3.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

4.  Admission hyperglycemia and outcome in ICU patients with sepsis.

Authors:  Chiara Robba; Federico Bilotta
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation.

Authors:  Chao Yue; Bingqiang Ma; Yunzhao Zhao; Qiurong Li; Jieshou Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

6.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

7.  Mathematical modeling of energy consumption in the acute inflammatory response.

Authors:  Ivan Ramirez-Zuniga; Jonathan E Rubin; David Swigon; Gilles Clermont
Journal:  J Theor Biol       Date:  2018-08-25       Impact factor: 2.691

Review 8.  Diabetes, insulin, and development of acute lung injury.

Authors:  Shyoko Honiden; Michelle N Gong
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

Review 9.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

10.  Exhaustive exercise causes an anti-inflammatory effect in skeletal muscle and a pro-inflammatory effect in adipose tissue in rats.

Authors:  José C Rosa Neto; Fábio S Lira; Lila M Oyama; Nelo E Zanchi; Alex S Yamashita; Miguel L Batista; Cláudia M Oller do Nascimento; Marília Seelaender
Journal:  Eur J Appl Physiol       Date:  2009-05-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.